Babak Razani MD PhD

PubMed

• Galectin-3 mediates lysosome-related inflammation within monocyte-derived macrophages in a mouse model of ischemic brain injury.
  Miao Wang, Zhentai Huang, Zhihong Du, Jiajing Shan, Qing Ye
  The Journal of Clinical Investigation. 2026-04-15
• Beneficial effects of SGLT1/2 and SGLT2 inhibitors on vaso-occlusive events and organ damage in sickle cell disease mice.
  Bo-Ram Jin, Tripti Kumari, Jingu Lee, Jae-Sung Kim, Radka Bokorova
  Cardiovascular Research. 2026-03-26
• 1 citations
  Sex-based multiomics analysis uncovers metabolic and molecular mediators linking MASH and atherosclerosis.
  Sandeep Das, Sumit Kumar Anand, M Peyton McKinney, Koral S E Richard, Iqbal Mahmud
  JHEP Reports. 2026-03-01

Journal Articles

• PPARγ Deficiency Suppresses the Release of IL-1β and IL-1α in Macrophages via a Type 1 IFN–Dependent Mechanism  
  Kassandra J Weber, Joel D Schilling, Babak Razani, The Journal of Immunology
• Ursolic acid enhances macrophage autophagy and attenuates atherosclerosis  
  Leng S, Iwanowycz S, Saaoud F, Wang J, Wang Y, Sergin I, Razani B, and Fan D., J Lipid Res, 1/1/2016
• Inclusion bodies enriched for p62 and polyubiquitinated proteins in macrophages protect against atherosclerosis  
  Sergin I, Bhattacharya S, Emanuel R, Esen E, Stokes CJ, Evans TD, Arif B, Curci JA, and Razani B., Sci Signal., 1/1/2016

Lectures

• Building a Better Macrophage to Treat Atherosclerosis and Associated Metabolic Conditions 
  Graz, Austria - 1/9/2016
• Building a Better Macrophage to Treat Metabolic Disease 
  Cedars-Sinai Medical Center, Los Angeles, CA - 1/8/2016
• Harnessing the Autophagy-Lysosomal Biogenesis Response in Macrophages to Treat Atherosclerosis 
  Vail, CO, 2015; Seoul, South Korea, 2015 - 1/12/2015

Other

• Orgocards: Organic Chemistry Review. 
  Wang SQ, Razani B, Lee EJK, Wu J, and Berkowitz W.
  1/1/2002